CVRx (CVRX) Work In Process (2020 - 2026)
CVRx's quarterly Work In Process came in at $623000.0 in Q1 2026, up 58.12% year-on-year from $394000.0 in Q1 2025, and up 31.71% quarter-over-quarter from $473000.0 in Q4 2025.
CVRx has reported Work In Process for 7 years, with the latest figure at $623000.0 in Q1 2026.
- For the quarter ending Q1 2026, Work In Process rose 58.12% year-over-year to $623000.0; the trailing twelve-month figure through Mar 2026 stood at $623000.0 (up 58.12% YoY), and the FY2025 full-year result was $473000.0, up 33.99% from the prior year.
- Work In Process for Q1 2026 stood at $623000.0, up from $473000.0 in the prior quarter.
- The five-year high for Work In Process was $2.3 million in Q2 2023, with the low at $139000.0 in Q3 2025.
- Average Work In Process over 5 years is $749764.7, with a median of $654000.0 recorded in 2023.
- Year-over-year, Work In Process jumped 219.51% in 2022 and tumbled 83.2% in 2025.
- Tracing CVRX's Work In Process over 5 years: stood at $1.0 million in 2022, then slumped by 36.69% to $654000.0 in 2023, then sank by 46.02% to $353000.0 in 2024, then surged by 33.99% to $473000.0 in 2025, then soared by 31.71% to $623000.0 in 2026.
- The last three Work In Process figures came in at $623000.0 (Q1 2026), $473000.0 (Q4 2025), and $139000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 623,000.00 |
| Dec 31, 2025 | 473,000.00 |
| Sep 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 230,000.00 |
| Mar 31, 2025 | 394,000.00 |
| Dec 31, 2024 | 353,000.00 |
| Sep 30, 2024 | 280,000.00 |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | 750,000.00 |
| Dec 31, 2023 | 654,000.00 |
| Sep 30, 2023 | 1.17 Mn |
| Jun 30, 2023 | 2.33 Mn |
| Mar 31, 2023 | 519,000.00 |
| Dec 31, 2022 | 1.03 Mn |
| Sep 30, 2022 | 917,000.00 |
| Jun 30, 2022 | 753,000.00 |
| Mar 31, 2022 | 753,000.00 |
| Dec 31, 2021 | 482,000.00 |
| Sep 30, 2021 | 287,000.00 |
| Jun 30, 2021 | 345,000.00 |
| Dec 31, 2020 | 321,000.00 |